Clinical Trial Update: Mixed Schedule Study of Live Oral Rotavirus Vaccines and Trivalent P2-VP8 Subunit Rotavirus Vaccine [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating mixed schedule of live oral rotavirus vaccines with a trivalent P2-VP8 subunit rotavirus vaccine has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rotavirus Vaccine-related Disease Rotavirus Infection in General

Drugs mentioned

• Live oral rotavirus vaccines
• Trivalent P2-VP8 subunit rotavirus vaccine (P2-VP8 subunit rotavirus vaccine (trivalent))

Snippet

Sponsor: PATH | Conditions: Rotavirus Vaccine | Phase 2 | Status: COMPLETED